• Western blot analysis of lysates from ovary cancer, using NF-kappaB p100/p52 (Phospho-Ser865) Antibody. The lane on the left is blocked with the phospho peptide.
  • Immunohistochemistry analysis of paraffin-embedded human breast carcinoma, using NF-kappaB p100/p52 (Phospho-Ser865) Antibody. The picture on the right is blocked with the phospho peptide.

Anti-Phospho-NFKB2-Ser865 antibody (833-882 aa) (STJ90341)

SKU:
STJ90341

Current Stock:
Host: Rabbit
Applications: WB/IHC/IP/IF/ELISA
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Phospho-Nuclear factor NF-kappa-B p100 subunit-Ser865 (833-882 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunoprecipitation, Immunofluorescence and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
IHC 1:100-1:300
IP 2-5 ug mg/lysate
IF 1:200-1:1000
ELISA 1:20000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: NFKB2
Gene ID: 4791
Uniprot ID: NFKB2_HUMAN
Immunogen Region: 833-882 aa
Specificity: Phospho-NF Kappa B-p100 (S865) Polyclonal Antibody detects endogenous levels of NF Kappa B-p100 protein only when phosphorylated at S865.
Immunogen: The antiserum was produced against synthesized peptide derived from the human NF-kappaB p100/p52 around the phosphorylation site of Ser865 at the amino acid range 833-882
Function NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. In a non-canonical activation pathway, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes. The NF-kappa-B heterodimeric RelB-p52 complex is a transcriptional activator. The NF-kappa-B p52-p52 homodimer is a transcriptional repressor. NFKB2 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p100 and generation of p52 by a cotranslational processing. The proteasome-mediated process ensures the production of both p52 and p100 and preserves their independent function. p52 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. p52 and p100 are respectively the minor and major form.the processing of p100 being relatively poor. Isoform p49 is a subunit of the NF-kappa-B protein complex, which stimulates the HIV enhancer in synergy with p65. In concert with RELB, regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-BMAL1 heterodimer.
Protein Name Nuclear Factor Nf-Kappa-B P100 Subunit
Dna-Binding Factor Kbf2
H2tf1
Lymphocyte Translocation Chromosome 10 Protein
Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B-Cells 2
Oncogene Lyt-10
Lyt10 Cleaved Into - Nuclear Factor Nf-Kappa-B P52 Subunit
Database Links Reactome: R-HSA-1810476
Reactome: R-HSA-3134963
Reactome: R-HSA-3214841
Reactome: R-HSA-445989
Reactome: R-HSA-448706
Reactome: R-HSA-4755510
Reactome: R-HSA-5603029
Reactome: R-HSA-5607761
Reactome: R-HSA-5676590
Reactome: R-HSA-844456
Reactome: R-HSA-933542
Reactome: R-HSA-9660826
Cellular Localisation Nucleus
Cytoplasm
Nuclear
But Also Found In The Cytoplasm In An Inactive Form Complexed To An Inhibitor (I-Kappa-B)
Alternative Antibody Names Anti-Nuclear Factor Nf-Kappa-B P100 Subunit antibody
Anti-Dna-Binding Factor Kbf2 antibody
Anti-H2tf1 antibody
Anti-Lymphocyte Translocation Chromosome 10 Protein antibody
Anti-Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B-Cells 2 antibody
Anti-Oncogene Lyt-10 antibody
Anti-Lyt10 Cleaved Into - Nuclear Factor Nf-Kappa-B P52 Subunit antibody
Anti-NFKB2 antibody
Anti-LYT10 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance